U.S. begins study on allergic reaction risk in Moderna, Pfizer vaccines

The U.S. National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to COVID-19 vaccines made by Moderna Inc and Pfizer Inc.